P-243: Prenatal Diagnosis Using Array CGH: Case Presentation
Authors
Abstract:
Background: Karyotype analysis has been the standard and reliable procedure for prenatal cytogenetic diagnosis since the 1970s. However, the major limitation remains requirement for cell culture, resulting in a delay of as much as 14 days to get the test results.CGH array technology has proven to be useful in detecting causative genomic imbalances or genetic mutations in as many as 15% of children with a normal conventional karyotype. We describe the use of array comparative genomic hybridization (aCGH) for prenatal diagnosis and the ability to detect abnormalities not detected by karyotype. Materials and Methods: A 26-year-old pregnant woman referred for prenatal diagnosis and genetic counseling at 27 weeks gestation because of an ultrasound detected fetal oligohydramnious and normal karyotype. She was offered array CGH analysis using a cytochip ISCA 4x44K oligonucelotide array. Parental samples were obtained concurrently to exclude maternal cell contamination and determine if copy number variations (CNVs) were de novo or inherited. Results: Whole-genome CGH array analysis on the DNA extracted from amniocytes detected a 17Mb deletion at 1q22-q25.1 or arr 1q22q25.1(154559773-171639287)x1. This deleted region encompassing at least 138 OMIM genes. After genetic counseling, the mother decided to continue the pregnancy. A female fetus was delivered at 37 weeks gestation by cesarean. She was diagnosed with bilateral cleft lip and palate, a transverse single palmar crease in right hand, a birth weight of 1800g, small hands and feet, hypotonia, short neck, normal head circumference, and a hemangioma on the back of the head. Conclusion: aCGH analysis of a fetus with normal karyotype and abnormal ultrasound finding is recommended.
similar resources
Array CGH in Fetal Medicine Diagnosis
About 2% to 5% of live births have at least one identifiable congenital anomaly at birth (Kalter and Warkany, 1983), ranging from mild to severe abnormalities that compromise the survival. Congenital malformations have been showing increasing importance as a cause of suffering and harm to health of the population, accounting for a large percentage of perinatal morbidity and mortality (De Galan-...
full textPrenatal detection of unbalanced chromosomal rearrangements by array CGH.
BACKGROUND Karyotype analysis has been the standard method for prenatal cytogenetic diagnosis since the 1970s. Although highly reliable, the major limitation remains the requirement for cell culture, resulting in a delay of as much as 14 days to obtaining test results. Fluorescent in situ hybridisation (FISH) and quantitative fluorescent PCR (QF-PCR) rapidly detect common chromosomal abnormalit...
full textP-112: PGS-Array-CGH Technique: New Technical Approach to Promotion ART Outcome
Background Chromosomal abnormalities are common in embryos from assisted reproductive technology, ranging from 60% abnormal embryos in women
full textWilliams-Beuren Syndrome: A Case Confirmed by Array-CGH Method
Williams-Beuren Syndrome (WBS) is a rare genetic disorder. The first cases of WBS were described by Williams et al. in 1961 and Beuren et al. in 1962 independently (1, 2). Williams reported on a group of children with supraval-vular aortic stenosis (SVAS), dysmorphic facies and mental retardation. Beuren presented a similar syndrome with the additional features of peripheral pulmonary stenosis ...
full textImproving molecular diagnosis of aniridia and WAGR syndrome using customized targeted array-based CGH
Chromosomal deletions at 11p13 are a frequent cause of congenital Aniridia, a rare pan-ocular genetic disease, and of WAGR syndrome, accounting up to 30% of cases. First-tier genetic testing for newborn with aniridia, to detect 11p13 rearrangements, includes Multiplex Ligation-dependent Probe Amplification (MLPA) and karyotyping. However, neither of these approaches allow obtaining a complete p...
full textI-45: FISH and Array CGH for PGD of Cancer
We developed several FISH approaches to enable preimplantation genetic diagnosis of cancer predisposition syndromes. An overview of the applications and the results of those PGDs will be provided. In addition we developed several novel tools to genome wide screen for CNVs and SNPs in single cells. Those technologies are now being applied for polar body, blastomere and blastocyst screening for c...
full textMy Resources
Journal title
volume 8 issue 2.5
pages 253- 253
publication date 2014-07-01
By following a journal you will be notified via email when a new issue of this journal is published.
Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023